... a natural, unmodified antisense oligonucleotide that down-regulates the key gap junction protein connexin43 to dampen inflammatory responses and enhance healing.They call it a gap junction modulator. Any questions? Learn more on the CoDa Therapeutics website. ClinicalTrials.gov lists eight Nexagon studies completed, recruiting, or in the works.
We also note that St John has not yet made our Oklahoma treatment center directory. Come on now, everybody. It's as easy as 3-2-1.
[Photo: News On 6, Tulsa]